Announcements Trials
Browse Landscape

Phase

Phase 1/2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Conditions

Neoplasms 1Hematologic Diseases 1

Interventions

Dexamethasone 4ruxolitinib 2pomalidomide 2daratumumab 2Tacrolimus 2Mycophenolic Acid 2Lenalidomide 2Cyclophosphamide 2Bortezomib 2sonidegib 1ricolinostat 1ponatinib 1nirogacestat 1fludarabine phosphate 1fludarabine 1dacetuzumab 1Vorinostat 1Stem Cell Transplantation 1Remifentanil 1Quality of Life 1Methotrexate 1Mesna 1Melphalan 1KW-2478 1Hsp90 inhibitor KU757 1Filgrastim 1Electrocardiography 1Cyclosporine 1Clinical Laboratory Techniques 1CPI-0610 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1/2 × Hematologic Diseases × Remifentanil × Clear all
NCT00213239 2019-12-02

A Dose Finding Study of Remifentanil and Propofol for Lumbar Punctures in Children

The Hospital for Sick Children

Phase 1/2 Completed
64 enrolled 5 charts

Hematologic Diseases, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡